Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Clinical trial NCT03578081 · COMPLETED
Trial details
- NCT number
- NCT03578081
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-20
- Primary completion
- 2021-11-08
- Enrollment
- 690
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.